Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 613504, 14 pages
http://dx.doi.org/10.1155/2010/613504
Review Article

Application of “omics” to Prion Biomarker Discovery

1Molecular PathoBiology, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada R3E 3R2
2Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada R3E 0W3

Received 24 July 2009; Revised 3 December 2009; Accepted 30 December 2009

Academic Editor: George Perry

Copyright © 2010 Rhiannon L. C. H. Huzarewich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. B. Prusiner, “Prions,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13363–13383, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Ladogana, M. Puopolo, E. A. Croes et al., “Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada,” Neurology, vol. 64, no. 9, pp. 1586–1591, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Brown, J.-P. Brandel, M. Preese, and T. Sato, “Iatrogenic Creutzfeldt-Jakob disease: the waning of an era,” Neurology, vol. 67, no. 3, pp. 389–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. A. Llewelyn, P. E. Hewitt, R. S. G. Knight et al., “Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion,” The Lancet, vol. 363, no. 9407, pp. 417–421, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Bishop, P. Hart, L. Aitchison et al., “Predicting susceptibility and incubation time of human-to-human transmission of vCJD,” The Lancet Neurology, vol. 5, no. 5, pp. 393–398, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. E. D. Belay, R. A. Maddox, E. S. Williams, M. W. Miller, P. Gambetti, and L. B. Schonberger, “Chronic wasting disease and potential transmission to humans,” Emerging Infectious Diseases, vol. 10, no. 6, pp. 977–984, 2004. View at Google Scholar · View at Scopus
  7. G. J. Raymond, A. Bossers, L. D. Raymond et al., “Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease,” The EMBO Journal, vol. 19, no. 17, pp. 4425–4430, 2000. View at Google Scholar · View at Scopus
  8. P. Gambetti, Z. Dong, J. Yuan et al., “A novel human disease with abnormal prion protein sensitive to protease,” Annals of Neurology, vol. 63, no. 6, pp. 697–708, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Blennow, A. Johansson, and H. Zetterberg, “Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease,” International Journal of Molecular Medicine, vol. 16, no. 6, pp. 1147–1149, 2005. View at Google Scholar · View at Scopus
  10. P. Sanchez-Juan, A. Green, A. Ladogana et al., “CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease,” Neurology, vol. 67, no. 4, pp. 637–643, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. A. J. E. Green, E. J. Thompson, G. E. Stewart et al., “Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 70, no. 6, pp. 744–748, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Ness, “Microarray analysis: basic strategies for successful experiments,” Molecular Biotechnology, vol. 36, no. 3, pp. 205–219, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mortazavi, B. A. Williams, K. McCue, L. Schaeffer, and B. Wold, “Mapping and quantifying mammalian transcriptomes by RNA-Seq,” Nature Methods, vol. 5, no. 7, pp. 621–628, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. B. T. Wilhelm, S. Marguerat, S. Watt et al., “Dynamic repertoire of a eukaryotic transcriptome surveyed at single-nucleotide resolution,” Nature, vol. 453, no. 7199, pp. 1239–1243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Rosenkranz, T. Borodina, H. Lehrach, and H. Himmelbauer, “Characterizing the mouse ES cell transcriptome with Illumina sequencing,” Genomics, vol. 92, no. 4, pp. 187–194, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. Bushati and S. M. Cohen, “MicroRNAs in neurodegeneration,” Current Opinion in Neurobiology, vol. 18, no. 3, pp. 292–296, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. T. Ingolia, S. Ghaemmaghami, J. R. S. Newman, and J. S. Weissman, “Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling,” Science, vol. 324, no. 5924, pp. 218–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Xiang, O. Windl, I. M. Westner et al., “Cerebral gene expression profiles in sporadic Creutzfeldt-Jakob disease,” Annals of Neurology, vol. 58, no. 2, pp. 242–257, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. A. Baker and L. Manuelidis, “Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 2, pp. 675–679, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Sorensen, S. Medina, D. Parchaliuk, C. Phillipson, C. Robertson, and S. A. Booth, “Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes,” BMC Genomics, vol. 9, article 114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Booth, C. Bowman, R. Baumgartner et al., “Identification of central nervous system genes involved in the host response to the scrapie agent during preclinical and clinical infection,” Journal of General Virology, vol. 85, no. 11, pp. 3459–3471, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. W. Xiang, O. Windl, G. Wünsch et al., “Identification of differentially expressed genes in scrapie-infected mouse brains by using global gene expression technology,” Journal of Virology, vol. 78, no. 20, pp. 11051–11060, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Riemer, S. Neidhold, M. Burwinkel et al., “Gene expression profiling of scrapie-infected brain tissue,” Biochemical and Biophysical Research Communications, vol. 323, no. 2, pp. 556–564, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. G. P. Sawiris, K. G. Becker, E. J. Elliott, R. Moulden, and R. G. Rohwer, “Molecular analysis of bovine spongiform encephalopathy infection by cDNA arrays,” Journal of General Virology, vol. 88, no. 4, pp. 1356–1362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. P. J. Skinner, H. Abbassi, B. Chesebro, R. E. Race, C. Reilly, and A. T. Haase, “Gene expression alterations in brains of mice infected with three strains of scrapie,” BMC Genomics, vol. 7, article 114, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Tang, W. Xiang, S. A. C. Hawkins, H. A. Kretzschmar, and O. Windl, “Transcriptional changes in the brains of cattle orally infected with the bovine spongiform encephalopathy agent precede detection of infectivity,” Journal of Virology, vol. 83, no. 18, pp. 9464–9473, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. G. M. Cosseddu, O. Andréoletti, C. Maestrale et al., “Gene expression profiling on sheep brain reveals differential transcripts in scrapie-affected/not-affected animals,” Brain Research, vol. 1142, no. 1, pp. 217–222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Dandoy-Dron, F. Guillo, L. Benboudjema et al., “Gene expression of scrapie: cloning of a new scrapie-responsive gene and the identification of increased levels of seven other mRNA transcripts,” Journal of Biological Chemistry, vol. 273, no. 13, pp. 7691–7697, 1998. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Rite, S. Argüelles, J. L. Venero et al., “Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration,” Journal of Neuroscience Research, vol. 85, no. 16, pp. 3607–3618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Brown, J. Webb, S. Rebus, A. Williams, and J. K. Fazakerley, “Identification of up-regulated genes by array analysis in scrapie-infected mouse brains,” Neuropathology and Applied Neurobiology, vol. 30, no. 5, pp. 555–567, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. E. M. Blalock, J. W. Geddes, K. C. Chen, N. M. Porter, W. R. Markesbery, and P. W. Landfield, “Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 7, pp. 2173–2178, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. Z.-L. Wu, J. R. Ciallella, D. G. Flood, T. M. O'Kane, D. Bozyczko-Coyne, and M. J. Savage, “Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease,” Neurobiology of Aging, vol. 27, no. 3, pp. 377–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. K. E. Wilson, R. Marouga, J. E. Prime et al., “Comparative proteomic analysis using samples obtained with laser microdissection and saturation dye labelling,” Proteomics, vol. 5, no. 15, pp. 3851–3858, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Zhang, L. Barker, D. Pinchev et al., “Mining biomarkers in human sera using proteomic tools,” Proteomics, vol. 4, no. 1, pp. 244–256, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Dufek, M. Hamanová, J. Lokaj et al., “Serum inflammatory biomarkers in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 15, no. 4, pp. 318–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Miele, H. Seeger, D. Marino et al., “Urinary a1-antichymotrypsin: a biomarker of prion infection,” PLoS ONE, vol. 3, no. 12, article e3870, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. L. R. Simon, L. Lamoureux, M. Plews et al., “The identification of disease-induced biomarkers in the urine of BSE infected cattle,” Proteome Science, vol. 6, article 23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Sihlbom, I. Kanmert, H. von Bahr, and P. Davidsson, “Evaluation of the combination of bead technology with SELDI-TOF-MS and 2-D DIGE for detection of plasma proteins,” Journal of Proteome Research, vol. 7, no. 9, pp. 4191–4198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Sasaki, K. Doh-ura, J. W. Ironside, and T. Iwaki, “Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies,” Acta Neuropathologica, vol. 103, no. 3, pp. 199–208, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. I. L. Goldknopf, E. A. Sheta, J. Bryson et al., “Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease,” Biochemical and Biophysical Research Communications, vol. 342, no. 4, pp. 1034–1039, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Hye, S. Lynham, M. Thambisetty et al., “Proteome-based plasma biomarkers for Alzheimer's disease,” Brain, vol. 129, no. 11, pp. 3042–3050, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Guillaume, C. Zimmermann, P. R. Burkhard, D. F. Hochstrasser, and J.-C. Sanchez, “A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease,” Proteomics, vol. 3, no. 8, pp. 1495–1499, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Brechlin, O. Jahn, P. Steinacker et al., “Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease,” Proteomics, vol. 8, no. 20, pp. 4357–4366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. T. C. W. Poon, “Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices,” Expert Review of Proteomics, vol. 4, no. 1, pp. 51–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. W. Winkler, M. Zellner, M. Diestinger et al., “Biological variation of the platelet proteome in the elderly population and its implication for biomarker research,” Molecular and Cellular Proteomics, vol. 7, no. 1, pp. 193–203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. P. L. Ross, Y. N. Huang, J. N. Marchese et al., “Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents,” Molecular and Cellular Proteomics, vol. 3, no. 12, pp. 1154–1169, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. S. E. Ong, B. Blagoev, I. Kratchmarova et al., “Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics,” Molecular and Cellular Proteomics, vol. 1, no. 5, pp. 376–386, 2002. View at Google Scholar · View at Scopus
  48. M. T. Cancilla, S. G. Penn, and C. B. Lebrilla, “Alkaline degradation of oligosaccharides coupled with matrix-assisted laser desorption/ionization Fourier transform mass spectrometry: a method for sequencing oligosaccharides,” Analytical Chemistry, vol. 70, no. 4, pp. 663–672, 1998. View at Google Scholar · View at Scopus
  49. M. J. Chalmers, C. L. Mackay, C. L. Hendrickson et al., “Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease,” Analytical Chemistry, vol. 77, no. 22, pp. 7163–7171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Ray, M. Britschgi, C. Herbert et al., “Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins,” Nature Medicine, vol. 13, no. 11, pp. 1359–1362, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Khaniya, L. Almeida, U. Basu et al., “Microarray analysis of differentially expressed genes from Peyer's patches of cattle orally challenged with bovine spongiform encephalopathy,” Journal of Toxicology and Environmental Health. Part A, vol. 72, no. 17-18, pp. 1008–1013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. L. Austbø, A. Kampmann, U. Müller-Ladner, E. Neumann, I. Olsaker, and G. Skretting, “Identification of differentially expressed genes in ileal Peyer's patch of scrapie-infected sheep using RNA arbitrarily primed PCR,” BMC Veterinary Research, vol. 4, article 12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. K. L. Brown, K. Stewart, D. L. Ritchie et al., “Scrapie replication in lymphoid tissues depends on prion protein- expressing follicular dendritic cells,” Nature Medicine, vol. 5, no. 11, pp. 1308–1312, 1999. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Lötscher, M. Recher, L. Hunziker, and M. A. Klein, “Immunologically induced, complement-dependent up-regulation of the prion protein in the mouse spleen: follicular dendritic cells versus capsule and trabeculae,” Journal of Immunology, vol. 170, no. 12, pp. 6040–6047, 2003. View at Google Scholar · View at Scopus
  55. N. A. Mabbott and M. E. Bruce, “The immunobiology of TSE diseases,” Journal of General Virology, vol. 82, no. 10, pp. 2307–2318, 2001. View at Google Scholar · View at Scopus
  56. N. A. Mabbott, F. Mackay, F. Minns, and M. E. Bruce, “Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie,” Nature Medicine, vol. 6, no. 7, pp. 719–720, 2000. View at Publisher · View at Google Scholar · View at Scopus
  57. N. A. Mabbott, J. Young, I. McConnell, and M. E. Bruce, “Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility,” Journal of Virology, vol. 77, no. 12, pp. 6845–6854, 2003. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Aucouturier and C. Carnaud, “The immune system and prion diseases: a relationship of complicity and blindness,” Journal of Leukocyte Biology, vol. 72, no. 6, pp. 1075–1083, 2002. View at Google Scholar · View at Scopus
  59. F. Guillerme-Bosselut, L. Forestier, C. Jayat-Vignoles et al., “Glycosylation-related gene expression profiling in the brain and spleen of scrapie-affected mouse,” Glycobiology, vol. 19, no. 8, pp. 879–889, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Sasaki, K. Doh-ura, J. W. Ironside, N. Mabbott, and T. Iwaki, “Clusterin expression in follicular dendritic cells associated with prion protein accumulation,” Journal of Pathology, vol. 209, no. 4, pp. 484–491, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Glatzel, E. Abela, M. Maissen, and A. Aguzzi, “Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease,” The New England Journal of Medicine, vol. 349, no. 19, pp. 1812–1820, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. C. Piubelli, M. Fiorini, G. Zanusso et al., “Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping,” Proteomics, vol. 6, supplement 1, pp. S256–S261, 2006. View at Google Scholar
  63. L. Cepek, P. Brechlin, P. Steinacker et al., “Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease,” Dementia and Geriatric Cognitive Disorders, vol. 23, no. 1, pp. 22–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. J.-C. Sanchez, E. Guillaume, P. Lescuyer et al., “Cystatin C as a potential cerebrospinal fluid marker for the diagnosis of Creutzfeldt-Jakob disease,” Proteomics, vol. 4, no. 8, pp. 2229–2233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. O. Carrette, I. Demalte, A. Scherl et al., “A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease,” Proteomics, vol. 3, no. 8, pp. 1486–1494, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. W.-M. Gao, M. S. Chadha, R. P. Berger et al., “A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic brain injury,” Journal of Neurotrauma, vol. 24, no. 1, pp. 43–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. L. Pucci, S. Triscornia, D. Lucchesi et al., “Cystatin C and estimates of renal function: searching for a better measure of kidney function in diabetic patients,” Clinical Chemistry, vol. 53, no. 3, pp. 480–488, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. A. Herbst, S. McIlwain, J. J. Schmidt, J. M. Aiken, C. D. Page, and L. Li, “Prion disease diagnosis by proteomic profiling,” Journal of Proteome Research, vol. 8, no. 2, pp. 1030–1036, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. T. C. Martin, J. Moecks, A. Belooussov et al., “Classification of signatures of Bovine Spongiform Encephalopathy in serum using infrared spectroscopy,” Analyst, vol. 129, no. 10, pp. 897–901, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Otto, J. Wiltfang, E. Schütz et al., “Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study,” British Medical Journal, vol. 316, no. 7131, pp. 577–582, 1998. View at Google Scholar · View at Scopus
  71. G. Miele, J. Manson, and M. Clinton, “A novel erythroid-specific marker of transmissible spongiform encephalopathies,” Nature Medicine, vol. 7, no. 3, pp. 361–363, 2001. View at Publisher · View at Google Scholar · View at Scopus
  72. A. R. Brown, A. R. A. Blanco, G. Miele et al., “Differential expression of erythroid genes in prion disease,” Biochemical and Biophysical Research Communications, vol. 364, no. 2, pp. 366–371, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. X. Li, Y. Gong, Y. Wang et al., “Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project,” Proteomics, vol. 5, no. 13, pp. 3423–3441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Ueno, T. Sakai, M. Yamaoka, R. Yoshida, and A. Tsugita, “Analysis of blood plasma proteins in patients with Alzheimer's disease by two-dimensional electrophoresis, sequence homology and immunodetection,” Electrophoresis, vol. 21, no. 9, pp. 1832–1845, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. P. Aucouturier, F. Geissmann, D. Damotte et al., “Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie,” Journal of Clinical Investigation, vol. 108, no. 5, pp. 703–708, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. F. Chrétien, G. Le Pavec, A.-V. Vallat-Decouvelaere et al., “Expression of excitatory amino acid transporter-1 (EAAT-1) in brain macrophages and microglia of patients with prion diseases,” Journal of Neuropathology and Experimental Neurology, vol. 63, no. 10, pp. 1058–1071, 2004. View at Google Scholar · View at Scopus
  77. A. Serban, G. Legname, K. Hansen, N. Kovaleva, and S. B. Prusiner, “Immunoglobulins in urine of hamsters with scrapie,” Journal of Biological Chemistry, vol. 279, no. 47, pp. 48817–48820, 2004. View at Publisher · View at Google Scholar · View at Scopus
  78. S. McHattie, G. A. H. Wells, J. Bee, and N. Edington, “Clusterin in bovine spongiform encephalopathy (BSE),” Journal of Comparative Pathology, vol. 121, no. 2, pp. 159–171, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. A. Dalrymple, E. J. Wild, R. Joubert et al., “Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates,” Journal of Proteome Research, vol. 6, no. 7, pp. 2833–2840, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. G. van Niel, I. Porto-Carreiro, S. Simoes, and G. Raposo, “Exosomes: a common pathway for a specialized function,” Journal of Biochemistry, vol. 140, no. 1, pp. 13–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. C. Robertson, S. A. Booth, D. R. Beniac, M. B. Coulthart, T. F. Booth, and A. McNicol, “Cellular prion protein is released on exosomes from activated platelets,” Blood, vol. 107, no. 10, pp. 3907–3911, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. B. Fevrier, D. Vilette, F. Archer et al., “Cells release prions in association with exosomes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 26, pp. 9683–9688, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. M. Prinz, M. Helkenwalder, T. Junt et al., “Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion,” Nature, vol. 425, no. 6961, pp. 957–962, 2003. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Zhou, T. Pisitkun, A. Aponte et al., “Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury,” Kidney International, vol. 70, no. 10, pp. 1847–1857, 2006. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Skog, T. Würdinger, S. van Rijn et al., “Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers,” Nature Cell Biology, vol. 10, no. 12, pp. 1470–1476, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Saba, C. D. Goodman, R. L. C. H. Huzarewich, C. Robertson, and S. A. Booth, “A miRNA signature of prion induced neurodegeneration,” PLoS ONE, vol. 3, no. 11, article e3652, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. W. J. Lukiw and A. I. Pogue, “Induction of specific micro RNA (miRNA) species by ROS-generating metal sulfates in primary human brain cells,” Journal of Inorganic Biochemistry, vol. 101, no. 9, pp. 1265–1269, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. J. Kim, K. Inoue, J. Ishii et al., “A microRNA feedback circuit in midbrain dopamine neurons,” Science, vol. 317, no. 5842, pp. 1220–1224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. J. Montag, R. Hitt, L. Opitz, W. J. Schulz-Schaeffer, G. Hunsmann, and D. Motzkus, “Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease,” Molecular Neurodegeneration, vol. 4, no. 1, article 36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Osaki, F. Takeshita, and T. Ochiya, “MicroRNAs as biomarkers and therapeutic drugs in human cancer,” Biomarkers, vol. 13, no. 7-8, pp. 658–670, 2008. View at Publisher · View at Google Scholar · View at Scopus